Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Directorate Change

12 Mar 2025 07:00

RNS Number : 2588A
4imprint Group PLC
12 March 2025
 

12 March 2025

4imprint Group plc

CFO Appointment

 

4imprint Group plc ("4imprint" or the "Company") today announces that Michelle Brukwicki will be appointed as CFO and a member of the Board with effect from 1 May 2025. On the same date, David Seekings will step down as CFO and from the Board, but will remain available to Michelle and the business until 30 June 2025 to ensure a continued smooth transition.

Paul Moody, Chair, commented: Alongside Kevin, David's contribution has been central to the phenomenal success that 4imprint has enjoyed over many years. His personal values and high integrity are evident in all that he has done and his positive commitment to all stakeholders has been unwavering. The Board sends its thanks and wishes him great success and happiness in the future.

Kevin Lyons-Tarr, CEO, commented: David's deep commitment to always doing the right thing for the business and its stakeholders has absolutely been an integral part of our success. From his first day with the Group through to his work to ensure a successful and effective succession, he has always given his very best. Working alongside him for more than two decades has truly been one of the highlights of my career. On behalf of everyone who has been part of the 4imprint journey I offer sincere thanks and best wishes to David and his family as he embarks on this next chapter. 

David Seekings, CFO, commented: During my 28 year career with the Company I have had the privilege of being part of a truly unique business at 4imprint. Over the years I have enjoyed working with many inspiring colleagues, including fellow Board members, Kevin and the leadership group, and all of the talented team members throughout the business who make 4imprint such an exceptional place to work. Whilst looking forward to a full and active retirement, I will miss my daily interactions with the 4imprint team, many of whom I can call my friends.

 

Notes: 

1. There is no further information in respect of Michelle Brukwicki which would require disclosure under Listing Rule 6.4.6.

2. Details of Michelle's remuneration arrangements were set out in the Company's announcement of 18 October 2024.

3. The information required to be disclosed under section 430(2B) of the Companies Act 2006 in relation to David Seekings will be available on the Company's website in due course. Consistent with his contractual terms and the Remuneration Policy, David will be paid salary, pension and benefits in the normal way until 30 June 2025. As a good leaver David will earn a pro rata FY25 bonus in relation to the period to 30 June 2025, and he will retain his outstanding deferred bonus awards, all subject to the relevant conditions. David will be bound by the post-cessation shareholding requirements in the Company's Remuneration Policy, requiring him to retain 4imprint shares to the value of 200% of base salary for a minimum of two years following his departure from the business. 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

Email: hq@4imprint.co.uk

MHP Group

Tel. + 44 (0) 7884 494112

Email: 4imprint@mhpgroup.com

 

 

Kevin Lyons-Tarr

Chief Executive Officer

 

Emma Taylor

Company Secretary

Katie Hunt

 

 

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDXGDBDGUB
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.